相关实验视频
Updated: May 7, 2026

14:49
Self-reporting Scaffolds for 3-Dimensional Cell Culture
Published on: November 7, 2013
13.2K
自报聚合体的合理设计,用于控制释放二氧化硫
Zhezhe Li1, Yue Zhang1, Suzhen Wang1
1School of Environmental and Chemical Engineering, Shanghai University, Shanghai 200444, China.
ACS macro letters
|November 27, 2024
概括
新的可生物降解聚合体释放二氧化硫 (SO2) 用于癌症治疗,并实时自我报告SO2水平. 这种双重功能为智能纳米医学和抗瘤应用提供了一个有前途的平台.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
背景情况:
- 二氧化硫 (SO2) 是一种涉及生物活动的气体调节剂,可以诱导癌细胞亡.
- 人们已经认识到SO2的治疗潜力,但控制释放和细胞内监测仍然是一个挑战.
- 现有的基于聚合物的SO2释放平台往往缺乏自我报告能力.
研究的目的:
- 设计和合成能够控制SO2释放的可生物降解聚合体.
- 整合一个自我报告机制,实时监测细胞内二氧化的产量.
- 评估这些聚合体作为抗瘤剂的潜力.
主要方法:
- 使用聚乙烯甘醇 (PEG) 和聚三甲烯碳酸盐 (PTMC) 基的SO2捐赠体制造聚合体.
- 评估由谷氨 (GSH) 触发的SO2释放.
- 对光变化进行实时SO2监测的评估.
- 在体外和体内研究,以评估抗瘤疗效.
主要成果:
- 开发的聚合体在GSH治疗后有效释放SO2.
- 该系统表现出光变化,使细胞内SO2的实时监测成为可能.
- 在体外和体内研究证实了SO2释放聚合体的抗瘤潜力.
结论:
- 成功开发了具有SO2释放和自我报告特性的可生物降解聚合体.
- 该系统为控制的SO2输送和实时细胞内监测提供了一个平台.
- 双功能聚合体对开发用于癌症治疗的智能纳米车辆具有重大前景.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

